Pharming (PHAR) Non-Current Debt (2019 - 2021)

Pharming's Non-Current Debt history spans 3 years, with the latest figure at $165000.0 for Q4 2021.

  • Quarterly results put Non-Current Debt at $165000.0 for Q4 2021, down 20.01% from a year ago — trailing twelve months through Dec 2021 was $165000.0 (down 20.01% YoY), and the annual figure for FY2021 was $165000.0, down 22.17%.
  • Non-Current Debt for Q4 2021 was $165000.0 at Pharming, down from $206266.1 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $19.1 million in Q4 2019 to a low of $165000.0 in Q4 2021.
  • The 3-year median for Non-Current Debt is $206266.1 (2020), against an average of $6.5 million.
  • The sharpest move saw Non-Current Debt crashed 98.92% in 2020, then dropped 20.01% in 2021.
  • Year by year, Non-Current Debt stood at $19.1 million in 2019, then crashed by 98.92% to $206266.1 in 2020, then dropped by 20.01% to $165000.0 in 2021.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $165000.0, $206266.1, and $19.1 million for Q4 2021, Q4 2020, and Q4 2019 respectively.